330 related articles for article (PubMed ID: 17234902)
1. Association between pulmonary function and sputum biomarkers in cystic fibrosis.
Mayer-Hamblett N; Aitken ML; Accurso FJ; Kronmal RA; Konstan MW; Burns JL; Sagel SD; Ramsey BW
Am J Respir Crit Care Med; 2007 Apr; 175(8):822-8. PubMed ID: 17234902
[TBL] [Abstract][Full Text] [Related]
2. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH
J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770
[TBL] [Abstract][Full Text] [Related]
3. Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis.
Sagel SD; Sontag MK; Wagener JS; Kapsner RK; Osberg I; Accurso FJ
J Pediatr; 2002 Dec; 141(6):811-7. PubMed ID: 12461498
[TBL] [Abstract][Full Text] [Related]
4. Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6.
Majka G; Mazurek H; Strus M; Ciszek-Lenda M; Szatanek R; Pac A; Golińska E; Marcinkiewicz J
Clin Exp Immunol; 2021 Sep; 205(3):391-405. PubMed ID: 34031873
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum.
Karandashova S; Kummarapurugu A; Zheng S; Kang L; Sun S; Rubin BK; Voynow JA
Pediatr Pulmonol; 2018 Jul; 53(7):872-880. PubMed ID: 29624923
[TBL] [Abstract][Full Text] [Related]
6. Relationship between sputum inflammatory markers, lung function, and lung pathology on high-resolution computed tomography in children with cystic fibrosis.
Dakin CJ; Pereira JK; Henry RL; Wang H; Morton JR
Pediatr Pulmonol; 2002 Jun; 33(6):475-82. PubMed ID: 12001282
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis.
Kim JS; Okamoto K; Rubin BK
Chest; 2006 May; 129(5):1148-54. PubMed ID: 16685004
[TBL] [Abstract][Full Text] [Related]
8. Safety and use of sputum induction in children with cystic fibrosis.
Suri R; Marshall LJ; Wallis C; Metcalfe C; Shute JK; Bush A
Pediatr Pulmonol; 2003 Apr; 35(4):309-13. PubMed ID: 12629630
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects.
Sloane AJ; Lindner RA; Prasad SS; Sebastian LT; Pedersen SK; Robinson M; Bye PT; Nielson DW; Harry JL
Am J Respir Crit Care Med; 2005 Dec; 172(11):1416-26. PubMed ID: 16166615
[TBL] [Abstract][Full Text] [Related]
10. Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.
Sagel SD; Gibson RL; Emerson J; McNamara S; Burns JL; Wagener JS; Ramsey BW; ;
J Pediatr; 2009 Feb; 154(2):183-8. PubMed ID: 18822427
[TBL] [Abstract][Full Text] [Related]
11. Prolastin aerosol therapy and sputum taurine in cystic fibrosis.
Cantin AM; Berthiaume Y; Cloutier D; Martel M
Clin Invest Med; 2006 Aug; 29(4):201-7. PubMed ID: 16986483
[TBL] [Abstract][Full Text] [Related]
12. Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study.
Ordoñez CL; Stulbarg M; Grundland H; Liu JT; Boushey HA
Pediatr Pulmonol; 2001 Jul; 32(1):29-37. PubMed ID: 11416873
[TBL] [Abstract][Full Text] [Related]
13. Lipoxin A(4) and interleukin-8 levels in cystic fibrosis sputum after antibiotherapy.
Chiron R; Grumbach YY; Quynh NV; Verriere V; Urbach V
J Cyst Fibros; 2008 Nov; 7(6):463-8. PubMed ID: 18541460
[TBL] [Abstract][Full Text] [Related]
14. Induced sputum nitrites correlate with FEV1 in children with cystic fibrosis.
Anil N; Singh M; Rajwanshi A; Vohra H
Acta Paediatr; 2010 May; 99(5):711-714. PubMed ID: 20096026
[TBL] [Abstract][Full Text] [Related]
15. Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis.
Sagel SD; Wagner BD; Anthony MM; Emmett P; Zemanick ET
Am J Respir Crit Care Med; 2012 Nov; 186(9):857-65. PubMed ID: 22904182
[TBL] [Abstract][Full Text] [Related]
16. Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis.
Laguna TA; Wagner BD; Luckey HK; Mann SA; Sagel SD; Regelmann W; Accurso FJ
Chest; 2009 Dec; 136(6):1561-1568. PubMed ID: 19567495
[TBL] [Abstract][Full Text] [Related]
17. Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease.
Thomas SR; Ray A; Hodson ME; Pitt TL
Thorax; 2000 Sep; 55(9):795-7. PubMed ID: 10950901
[TBL] [Abstract][Full Text] [Related]
18. Digitoxin for Airway Inflammation in Cystic Fibrosis: Preliminary Assessment of Safety, Pharmacokinetics, and Dose Finding.
Zeitlin PL; Diener-West M; Callahan KA; Lee S; Talbot CC; Pollard B; Boyle MP; Lechtzin N
Ann Am Thorac Soc; 2017 Feb; 14(2):220-229. PubMed ID: 28006108
[TBL] [Abstract][Full Text] [Related]
19. Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis.
Liou TG; Adler FR; Argel N; Asfour F; Brown PS; Chatfield BA; Daines CL; Durham D; Francis JA; Glover B; Heynekamp T; Hoidal JR; Jensen JL; Keogh R; Kopecky CM; Lechtzin N; Li Y; Lysinger J; Molina O; Nakamura C; Packer KA; Poch KR; Quittner AL; Radford P; Redway AJ; Sagel SD; Sprandel S; Taylor-Cousar JL; Vroom JB; Yoshikawa R; Clancy JP; Elborn JS; Olivier KN; Cox DR
BMC Med Res Methodol; 2019 Apr; 19(1):88. PubMed ID: 31027503
[TBL] [Abstract][Full Text] [Related]
20. Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis.
Dittrich AS; Kühbandner I; Gehrig S; Rickert-Zacharias V; Twigg M; Wege S; Taggart CC; Herth F; Schultz C; Mall MA
Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29545279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
